Robert M Deacon

Title: The Innovations of Robert M Deacon

Introduction

Robert M Deacon is a notable inventor based in Swindon, Wilts, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds with therapeutic applications. His work has garnered attention for its potential in treating various health conditions.

Latest Patents

One of Robert M Deacon's key patents is for 2-thiazolyl-imidazo[1,2,-a]pyrimidines. This compound is characterized by a specific formula where R1 is thiazol-2-yl, which may be substituted by one or two alkyl groups of 1 to 3 carbon atoms. Additionally, these alkyl groups can be further substituted by fluorine or --COOAlk, where Alk represents an alkyl group of 1 to 3 carbon atoms. The patent also details that R2 and R3 can be hydrogen, alkyl, or alkenyl groups, or they can form an alkylene chain. The compound is noted for its non-toxic, pharmaceutically acceptable acid addition salts, which exhibit minor tranquillizing activity and are useful for treating obesity and cognitive impairment.

Career Highlights

Robert M Deacon is associated with Roussel Uclaf, a company known for its focus on pharmaceutical innovations. His work at the company has been instrumental in advancing research and development in the field.

Collaborations

Throughout his career, Robert has collaborated with notable colleagues, including Roger J Gillespie and Colin R Gardner. These collaborations have contributed to the successful development of innovative compounds and have enhanced the research output of their projects.

Conclusion

Robert M Deacon's contributions to the field of pharmaceuticals, particularly through his patent on 2-thiazolyl-imidazo[1,2,-a]pyrimidines, highlight his role as an influential inventor. His work continues to impact the treatment of significant health issues, showcasing the importance of innovation in medicine.